Related Experiment Video
Updated: Aug 5, 2026

Amplicon Sequencing using the Long-Read Sequencing Technologies
Published on: August 29, 2025
Metagenomic next-generation sequencing for tuberculosis diagnosis: enhanced performance and cost-effectiveness
Xiaoli Zhou1, Guo Wei2, Tiange Song1
1Department of Laboratory Medicine, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Metagenomic next-generation sequencing (mNGS) shows high specificity for diagnosing tuberculosis (TB). A sequential approach using mNGS after conventional tests improves diagnostic accuracy and becomes cost-effective with increased healthcare investment.
Area of Science:
- Clinical microbiology and infectious diseases.
- Genomic medicine and diagnostics.
- Health economics and outcomes research.
Background:
- Metagenomic next-generation sequencing (mNGS) is an emerging tool for diagnosing complex infections like tuberculosis (TB).
- Previous research primarily focused on case-specific applications of mNGS in TB diagnosis, lacking systematic evaluation.
- A comprehensive assessment of mNGS's diagnostic performance and cost-effectiveness compared to established methods is needed.
Purpose of the Study:
- To systematically evaluate the diagnostic performance and cost-effectiveness of mNGS for TB diagnosis in a large real-world cohort.
- To compare mNGS against six conventional TB diagnostic assays: tuberculosis IgG antibody, TB interferon-γ release assay (TB-IGRA), TB-DNA, Xpert MTB/RIF (Xpert), culture, and acid-fast bacilli staining (AFS).
- To assess the utility of a sequential diagnostic strategy involving mNGS.
Main Methods:
- Retrospective observational study analyzing 16,776 results from 3,757 patients with suspected TB infection.
- Comparison of diagnostic metrics (sensitivity, specificity, accuracy, AUC) against a composite reference standard.
- Microbial composition analysis and cost-utility analysis of mNGS strategies.
Main Results:
- mNGS exhibited the highest specificity (100%), accuracy (72.3%), and AUC (0.795) among the seven assays.
- Sequential use of mNGS after WHO-recommended tests (Xpert/Culture/AFS) significantly improved diagnostic performance (sensitivity 70.4%, AUC 0.823).
- The sequential mNGS strategy demonstrated cost-effectiveness at higher willingness-to-pay thresholds (>200,000 RMB per correct diagnosis).
Conclusions:
- mNGS offers superior specificity for diagnosing TB, particularly in challenging cases.
- A sequential strategy utilizing mNGS for conventional-test-negative patients enhances diagnostic performance.
- This sequential approach is cost-effective at higher healthcare investment levels, supporting its integration into TB diagnostic algorithms.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Modern Molecular Taxonomy
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Automated Microbial Diagnostics
Rapid Identification of Pathogens

